Florida mushroom contains both psilocybin and toxic amatoxins

The collaboration included Ben Lemmond from Smith's laboratory; Michael Christopher and Timothy Garrett from UF Chemistry; Dentinger from Utah; and Jason Slot from Ohio State. Kunik, Smith and those colleagues found that a mushroom looking much like other small brown species contained both compounds, an unusual chemical combination.

How could one fungus gain both chemical traits?

Horizontal gene transfer allows genetic material to move between organisms that are not close relatives, rather than only passing from one generation to the next. The genes responsible for producing psilocybin and amatoxins likely entered Galerina through at least two separate transfers. That explanation fits the team's analysis, but it remains an inference from genetic evidence, not a directly observed evolutionary history.

Dentinger compared the process to a handshake in which some of one person's DNA becomes incorporated into another person's genome. The metaphor makes a distant transfer easier to picture, although it does not identify the organisms involved or the original source of either compound's genes.

What might the compounds do? Kunik said scientists still do not fully understand why mushrooms produce psilocybin. Amatoxins may help protect fungi from animals that eat them, but their precise ecological role remains unclear. Why one mushroom makes both substances, and what advantage that might confer, are open questions rather than demonstrated benefits.

Future experiments could “knock out,” or disable, genes for producing either compound and then observe how the mushroom changes. Such tests might reveal whether one chemical protects the fungus, whether psilocybin serves some other function, or whether making both offers an advantage. The current study sets up those tests; it does not answer them.

What does this change for mushroom gatherers?

For anyone tempted to forage wild mushrooms, the practical answer is blunt: this discovery supplies no reliable field test. Smith said the mushrooms are hard to find, small and brown like hundreds of others, and difficult to distinguish even for trained experts. The finding gives no basis for treating blue staining alone as a safety signal.

That is an inference from the documented identification difficulty, not a new finding about poisoning. The report gives no compound concentrations, does not say whether every specimen shares the same chemical profile, and includes no account of human or animal poisoning caused by G. indica.

For suspected ingestions, Smith's own practice points to expert identification and consultation with Florida Poison Control, emergency doctors or veterinarians.

The species has been documented only a handful of times worldwide. Specimens used in the research now form part of the Natural History Museum of Utah's collection and remain available for future study. Kunik, now a postbaccalaureate researcher at Harvard, continues his fungal research. He sees small, seemingly uninteresting fungi as capable of concealing extraordinary chemistry that scientists are only beginning to understand.

What is still unknown?

The clearest result is chemical: the team detected both psilocybin and amatoxins in G. indica. The explanations remain open. The research does not establish the compounds' amounts, ecological functions, clinical effects in this species, or the advantages of producing both.

A remarkable pairing, in other words, is not the same as a solved biological mechanism.